INVO Bioscience (NASDAQ:INVO) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement.
Analysts estimate that INVO Bioscience will report an earnings per share (EPS) of $-0.24.
Gainers
Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.